Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Gout Linked with Impaired Arterial Responsiveness

Clin Rheumatol; ePub 2018 Feb 15; Krasnokutsky, et al

Compared with healthy controls, subjects with gout have reduced arterial function, according to a recent study. Individual comorbidities are insufficient to account for differences between gout and control groups, but multiple comorbidities may collectively contribute to impairment in endothelium-dependent arterial responsiveness. Endothelial impairment is also related to serum rate (sUA) and high-sensitivity C-reactive protein (hsCRP), markers of gout severity and inflammation, respectively. Researchers conducted a cross-sectional study of untreated gout subjects (n=34) and non-gout healthy controls (n=64). High-resolution dynamic ultrasound-measured flow-mediated dilation (FMD) and nitroglycerin-mediated dilation (NMD) assessed endothelium-dependent and endothelium-independent arterial responsiveness, respectively. sUA and hsCRP were measured in the gout group, and correlated with FMD and NMD responses. They found:

  • Both FMD and NMD were impaired in the gout vs control group.
  • Stratification for individual comorbidities suggested that no single risk factor accounted for impaired FMD/NMD in the gout subjects.
  • However, the degree of association between gout and FMD, but not NMD impairment, was dampened after multivariable adjustment.
  • Within the gout group, there was an inverse correlation between FMD and sUA, and between FMD and hsCRP, but not between NMD and sUA or hsCRP.


Krasnokutsky S, Romero AG, Bang D, et al. Impaired arterial responsiveness in untreated gout patients compared with healthy non-gout controls: association with serum urate and C-reactive protein. [Published online ahead of print February 15, 2018]. Clin Rheumatol. doi:10.1007/s10067-018-4029-y.

This Week's Must Reads

Inverse U-Shaped Link Between CRP, Systolic BP in RA, Arthritis Res Ther; 2018 Jun 1; Yu, Kim, Vanni, et al

Exercise Linked with Protective CV Risk in RA , J Clin Rheumatol; 2018 ePub May 25; Byram, et al

No Link Between Coffee Consumption and Incident RA, J Clin Rheumatol; ePub 2018 Apr 19; Lamichhane, et al

PROMIS Forms Capture Fatigue Experience in RA, Qual Life Res; ePub 2018 May 24; Bartlett, et al

MBDA Score Independently Predictive of Relapsing RA, PLoS One; ePub 2018 May 23; Moghadam, et al

Must Reads in Gout

Statin Use Linked with Lower Mortality in Gout, Semin Arthritis Rheum; ePub 2018 Mar 17; Keller, et al

Gout Linked with Impaired Arterial Responsiveness, Clin Rheumatol; ePub 2018 Feb 15; Krasnokutsky, et al

Gout Management Program Improved Outcomes, Arthritis Care Res; ePub 2018 Feb 13; Bulbin, et al

Incidence of Gout Has More than Doubled in US, J Rheumatol; ePub 2017 Dec 15; Elfishawi, et al

Gout Self-Management in African American Veterans, Arthritis Care Res; ePub 2017 Sep 26; Singh, Herbey, et al